Completed
PHASE4
INTERVENTIONAL
NCT03308643
Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
To evaluate the effects of oxytocin infusion during abdominal myomectomy.
Detailed Description
Myomectomy is indicated for symptomatic uterine fibroids. Fibroids have blood supply and 20% of the abdominal myomectomy cases might require blood transfusion because of the nature of the surgery. Oxytocin infusion is one of the intervention to decrease blood loss during myomectomy. To evaluate the effects and benefits of oxytocin infusion during abdominal myomectomy we decide to conduct this randomized study.
Interventions
Name:
Oxytocin
Type:
DRUG
Description:
Patients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia.
Name:
saline
Type:
OTHER
Description:
Patients will receive intravenous normal saline infusion just before the surgery after the induction of general anesthesia.
Primary Outcomes
Measure:
Blood loss during surgery
TimeFrame:
2 hours
Description:
estimated blood loss during the surgery measured by aspiration fluid.
Trial Information
NCT ID
NCT03308643
Status
Completed
Study Type
INTERVENTIONAL
Phases
PHASE4
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Last Updated
December 15, 2025